Fluid-Based Biomarker Scientist

As newer blood-based markers for Alzheimer’s disease (AD) and related disorders (ADRD) become a reality, there is urgent need to determine when the proteinopathies become detectable in blood relative to age and risk factors, how they relate to established imaging and cerebrospinal markers, and how they perform in diverse ethnoracial and socioeconomic communities. Further, there is great need to determine how blood markers may be best applied in several use contexts including as screening and outcome measures for clinical trials and observational studies, and for patient diagnosis and management in community clinical settings. Read full job posting.